We are live on ! Find out more
GCM

Geneva Capital Management Portfolio holdings

AUM $4.71B
1-Year Est. Return 6.32%
This Fund
S&P 500
This Quarter Est. Return
+9.33%
1 Year Est. Return
+6.32%
3 Year Est. Return
+44.91%
5 Year Est. Return
+59.73%
10 Year Est. Return
AUM
$4.45B
AUM Growth
+$122M
Cap. Flow
-$134M
Cap. Flow %
-3%
Top 10 Hldgs %
26.71%
Holding
130
New
2
Increased
35
Reduced
87
Closed
6

Sector Composition

1 Technology 35.48%
2 Industrials 26.91%
3 Healthcare 15.32%
4 Consumer Discretionary 8.86%
5 Financials 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FICO icon
1
Fair Isaac
FICO
$28.8B
$160M 3.59%
266,728
+48
+0% +$25.3K
KNSL icon
2
Kinsale Capital Group
KNSL
$7.85B
$143M 3.2%
545,512
-124,535
-19% -$35.9M
EXLS icon
3
EXL Service
EXLS
$4.31B
$141M 3.16%
4,147,145
-16,220
-0.4% -$564K
EXPO icon
4
Exponent
EXPO
$3.06B
$138M 3.1%
1,392,518
-1,921
-0.1% -$187K
RBC icon
5
RBC Bearings
RBC
$18.3B
$120M 2.7%
573,890
-459
-0.1% -$105K
GMED icon
6
Globus Medical
GMED
$10.4B
$106M 2.38%
1,424,326
+18,555
+1% +$1.26M
FOXF icon
7
Fox Factory Holding Corp
FOXF
$791M
$103M 2.32%
1,129,923
-1,044
-0.1% -$97.1K
DSGX icon
8
Descartes Systems
DSGX
$6.37B
$99.3M 2.23%
1,425,085
+2,965
+0.2% +$203K
BCPC
9
Balchem Corp
BCPC
$5.26B
$91.6M 2.06%
750,324
+23,776
+3% +$3.14M
NOVT icon
10
Novanta
NOVT
$5.29B
$88.1M 1.98%
648,444
+628
+0.1% +$87.9K
TECH icon
11
Bio-Techne
TECH
$11.2B
$87.8M 1.97%
1,059,500
-6,072
-0.6% -$482K
AAON icon
12
Aaon
AAON
$9.12B
$83.7M 1.88%
1,667,415
-2,871
-0.2% -$134K
ONTO icon
13
Onto Innovation
ONTO
$13.8B
$83M 1.87%
1,219,456
-2,683
-0.2% -$193K
ESE icon
14
ESCO Technologies
ESE
$8.27B
$75.2M 1.69%
859,225
+527
+0.1% +$45.4K
TXRH icon
15
Texas Roadhouse
TXRH
$12.9B
$72.9M 1.64%
801,988
+1,161
+0.1% +$112K
ROAD icon
16
Construction Partners
ROAD
$5.91B
$71.3M 1.6%
2,671,078
+253,139
+10% +$7.25M
BL icon
17
BlackLine
BL
$1.76B
$70.4M 1.58%
1,046,913
-63,836
-6% -$3.96M
AQUA
18
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$68.7M 1.54%
1,734,219
+1,957
+0.1% +$77K
PLUS icon
19
ePlus
PLUS
$2.3B
$67.3M 1.51%
1,520,532
-1,606
-0.1% -$74.9K
ENV
20
DELISTED
ENVESTNET, INC.
ENV
$65.8M 1.48%
1,066,352
-1,100
-0.1% -$58.6K
EVOP
21
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$65.6M 1.47%
1,938,489
+5,579
+0.3% +$188K
PRFT
22
DELISTED
Perficient Inc
PRFT
$65.6M 1.47%
939,379
+13,973
+2% +$964K
MRTN icon
23
Marten Transport
MRTN
$1.44B
$65M 1.46%
3,287,709
+3,145
+0.1% +$62.8K
JJSF icon
24
J&J Snack Foods
JJSF
$1.43B
$64.7M 1.45%
432,500
+7,973
+2% +$1.18M
ALRM icon
25
Alarm.com
ALRM
$2.64B
$63.5M 1.43%
1,284,235
-12,408
-1% -$684K

Similar funds

Geneva Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Geneva Capital Management held 130 positions worth $4.45B, up 2.8% from $4.33B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Geneva Capital Management withdrew a net $134M in Q4 2022, closing 6 positions and reducing 87 holdings. Its most notable exit was LHC Group LLC, an estimated $35.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Geneva Capital Management opened a new position in Vanguard Small-Cap Growth ETF worth $2.91M.

  • Geneva Capital Management's largest Q4 2022 buy was Vanguard Small-Cap Growth ETF: 14,518 shares worth $2.91M.
  • Geneva Capital Management added most to Mesa Laboratories in Q4 2022, an estimated $13.6M increase.
  • Geneva Capital Management's biggest Q4 2022 reduction was Kinsale Capital Group, cutting an estimated $35.9M.
  • Geneva Capital Management fully exited LHC Group LLC in Q4 2022, selling an estimated $35.3M.
  • Geneva Capital Management's ten largest holdings make up 27% of its $4.45B portfolio in Q4 2022.
  • Geneva Capital Management opened 2 new positions and closed 6 in Q4 2022.
  • Geneva Capital Management's portfolio value rose 2.8% quarter-over-quarter to $4.45B.

Based on Geneva Capital Management's 13F filing for Q4 2022, filed 7 Feb 2023.